rahulmodiweightlosscoach post

Audited April 9, 2026 · by PeptIQ

No Evidence

After comprehensive searching across scientific databases, no evidence was found to substantiate the claims about Retratrutide's effects on tumor dynamics, immunological pathways, or cellular interactions. Further research and clinical validation are required to establish any potential therapeutic mechanisms.

Post captionshow

A doctor-led breakdown of why reta reduced tumor volume in preclinical cancer models. This wasn’t about killing cancer cells. It was about changing the biology cancer depends on. Reta improved insulin sensitivity and glucose control Reduced obesity-driven hormonal signaling Shifted the tumor immune environment toward anti-tumor activity Limited the metabolic pathways tumors use to grow When met

Show full post caption

abolic health improves and immune suppression drops, tumor progression slows. That’s the mechanism discussed here. Human studies are still yet to be done. Educational discussion only. Not medical advice. Always consult a qualified healthcare professional before starting or stopping any medication or pep. #cancer #wellness #weightloss #health #medical

Show less
Video transcriptshow

Retrotrutide has mostly been talked about for weight loss, but there's a study that came out this year that talks about how it affects cancer progression. This paper is from March of 2025 and it hasn't gone viral, but I want to see what the researchers were trying to understand here. The effects of retrotrutide on metabolic changes related to tumor progression and development, specifically in panc

Show full video transcript

reatic and lung adenocarcinoma. And so that makes a lot of sense because we already know obesity leads to many other diseases, but what do they find in this study? Reditrutide decreased tumor engraftment, delayed tumor onset, and reduced tumor growth over time. So fewer tumors found, they showed up later, and they grew much slower. So was this just a mechanism of weight loss or did the study account for other things there? In this study, they also compared it to semaglutide as a separate group, but what they did do was they had calorie restricted and weight matched groups and retitutide showed far better tumor suppression than the other groups. Retitutide did so through increasing antigen presenting cells, decreasing immunosuppressive cells, and increasing pro-inflammatory pathways related to tumor progression. So then what happened after they stopped the drug in some models? Even after stopping retatrutide, we saw in the control groups that tumor progression was slower. All right, so this is some pretty cool data. Now, how should we interpret this result, and what does this mean for cancer? This doesn't mean that retatrutide is a cancer treatment like chemotherapy. It only means that mediating the metabolic health and immune function can positively affect cancer outcomes. Now, retatrutide still needs to be tested for human cancer progression. However, this is a good starting point and this is how science should be talked about. Cool, calm, and collected. Just interpreting data.

Show less

Claim Breakdown(6 claims found)

1

Retratrutide decreased tumor engraftment in preclinical models.

No Evidence

No scientific literature was found supporting the claim that Retratrutide decreases tumor engraftment in preclinical models.

2

Retratrutide delayed tumor onset in preclinical models.

No Evidence

No scientific literature was found supporting the claim that Retratrutide delays tumor onset in preclinical models.

3

Retratrutide reduced tumor growth over time in preclinical models.

No Evidence

No scientific literature was found supporting the claim that Retratrutide reduces tumor growth over time in preclinical models.

4

Retratrutide increases antigen presenting cells.

No Evidence

No scientific literature was found supporting the claim that Retratrutide increases antigen presenting cells.

5

Retratrutide decreases immunosuppressive cells.

No Evidence

No scientific literature was found supporting the claim that Retratrutide decreases immunosuppressive cells.

6

Retratrutide increases pro-inflammatory pathways related to tumor progression.

No Evidence

No scientific literature was found supporting the claim that Retratrutide increases pro-inflammatory pathways related to tumor progression.

Share this audit

Preview post text
❌ AI fact-checked @rahulmodiweightlosscoach's peptide claims:

Verdict: NO EVIDENCE
After comprehensive searching across scientific databases, no evidence was found to substantiate the…
6 claims checked vs PubMed.

Full breakdown 👇
https://peptiq.io/check/2e95fd11-2929-41d6-966b-cfd6ff4cf537

@peptiq.io #PeptideScience #Biohacking
https://peptiq.io/check/2e95fd11-2929-41d6-966b-cfd6ff4cf537

Audit another post

3 free per day, no account needed

New audit

Track your peptide protocols

Download the PeptIQ app for dosing, logging, and more

Get the app

This audit is for educational purposes only. Not medical advice. Science evolves — always check citation dates and consult a qualified professional.

Report an error